RecruitingNCT07460531

Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failure


Sponsor

LMU Klinikum

Enrollment

2,000 participants

Start Date

Feb 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

SOPHIE is a prospective, multicentre, observational cohort study aiming to enrol 2,000 CHF patients. Baseline assessments include validated PA questionnaires (GPAQ, IPAQ, KCCQ) and seven-day step counts from commercially available pedometer devices. Follow-up is conducted every six months via telephone, repeating PA assessments and recording cardiovascular events, hospitalisations, and patient-reported outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Heart failure NT-proBNP \>600 pg/ml (at least once in the history) NYHA-Class II-IV HFrEF - heart failure with reduced ejection fraction; LVEF ≤40% or HFmrEF - heart failure with mildly reduced ejection fraction; LVEF 41% - 49% or HFpEF - heart failure with preserved ejection fraction; LVEF ≥50%
  • Age ≥18 years old
  • Willingness to participate in the study, confirmed by a signed informed consent form
  • Ownership of a pedometer (e.g. smartwatch, activity tracker, smartphone-app, analogical pedometer)

Exclusion Criteria2

  • Disease or disability that prevents physical activity
  • Hospitalisation due to heart failure within the last three months

Locations(2)

LMU University Hospital

Munich, Bavaria, Germany

Central Hospital of Bolzano

Bolzano, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07460531


Related Trials